Prokidney (PROK) Free Cash Flow (2021 - 2026)
Prokidney (PROK) reported Free Cash Flow of -$45.5 million for Q1 2026, down 47.98% year-over-year from -$87.4 million in Q1 2025, and down 18.83% quarter-over-quarter from -$38.3 million in Q4 2025.
Prokidney (PROK) Free Cash Flow (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Free Cash Flow data on file, last reported at -$45.5 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$45.5 million, down 47.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$150.1 million (up 0.61% YoY), and the FY2025 annual result was -$135.3 million, up 13.18% from the prior year.
- Free Cash Flow fell to -$45.5 million in Q1 2026 per PROK's latest filing, from -$38.3 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$16.1 million in Q4 2022 and troughed at -$51.7 million in Q3 2023.
- A 5-year average of -$31.8 million and a median of -$31.6 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow plunged 11810044.93% in 2022, then jumped 38.81% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$16.1 million in 2022, then slumped by 67.77% to -$27.0 million in 2023, then tumbled by 84.3% to -$49.7 million in 2024, then increased by 22.98% to -$38.3 million in 2025, then declined by 18.83% to -$45.5 million in 2026.
- Business Quant data shows PROK's Free Cash Flow at -$45.5 million in Q1 2026, -$38.3 million in Q4 2025, and -$31.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -45.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.47 Mn |
| Mar 31, 2026 | -45.47 Mn |
| Dec 31, 2025 | -38.27 Mn |
| Dec 31, 2025 | -38.27 Mn |
| Sep 30, 2025 | -31.79 Mn |
| Sep 30, 2025 | -31.79 Mn |
| Jun 30, 2025 | -34.53 Mn |
| Jun 30, 2025 | -34.53 Mn |
| Mar 31, 2025 | -30.73 Mn |
| Mar 31, 2025 | -30.73 Mn |
| Dec 31, 2024 | -49.68 Mn |
| Dec 31, 2024 | -49.68 Mn |
| Sep 30, 2024 | -31.65 Mn |
| Sep 30, 2024 | -31.65 Mn |
| Jun 30, 2024 | -38.93 Mn |
| Jun 30, 2024 | -38.93 Mn |
| Mar 31, 2024 | -35.61 Mn |
| Mar 31, 2024 | -35.61 Mn |
| Dec 31, 2023 | -26.96 Mn |
| Dec 31, 2023 | -26.96 Mn |